Α multicenter phase II study of pegylated liposomal doxorubicin in combination with irinotecan as second-line treatment of patients with refractory small-cell lung cancer-Reference-Cited by-同舟云学术

Α multicenter phase II study of pegylated liposomal doxorubicin in combination with irinotecan as second-line treatment of patients with refractory small-cell lung cancer

Published:2010-09-10 Issue:1 Volume:68 Page:63-68
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Xenidis Nikolaos,Vardakis Nikolaos,Varthalitis Ioannis,Giassas Stylianos,Kontopodis Emmanouel,Ziras Nikolaos,Gioulbasanis Ioannis,Samonis George,Kalbakis Kostas,Georgoulias Vassilis

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-010-1427-5.pdf

Reference26 articles.

1. Fried DB, Morris DE, Poole C, Rosenman JG, Halle JS, Detterbeck FC, Hensing TA, Socinski MA (2004) Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer. J Clin Oncol 22:4837–4845

2. Brahmer JR, Ettinger DS (1998) Carboplatin in the treatment of small cell lung cancer. Oncologist 3:143–154

3. Pujol JL, Carestia L, Daures JP (2000) Is there a case for cisplatin in the treatment of small-cell lung cancer? A meta-analysis of randomized trials of a cisplatin-containing regimen versus a regimen without this alkylating agent. Br J Cancer 83:8–15

4. Jackman DM, Johnson BE (2005) Small-cell lung cancer. Lancet 366:1385–1396

5. Huisman C, Postmus PE, Giaccone G, Smit EF (1999) Second-line chemotherapy and its evaluation in small cell lung cancer. Cancer Treat Rev 25:199–206

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of liposomes for targeted drug delivery in lung cancer treatment;International Journal of Polymeric Materials and Polymeric Biomaterials;2023-01-03

2. Liposomal formulations for lung cancer treatment in the last two decades: a systematic review;Journal of Cancer Research and Clinical Oncology;2022-06-04

3. Nanotechnology: Breaking the Current Treatment Limits of Lung Cancer;Advanced Healthcare Materials;2021-05-21

4. Irinotecan and berberine co-delivery liposomes showed improved efficacy and reduced intestinal toxicity compared with Onivyde for pancreatic cancer;Drug Delivery and Translational Research;2021-01-15

5. Effective co-encapsulation of doxorubicin and irinotecan for synergistic therapy using liposomes prepared with triethylammonium sucrose octasulfate as drug trapping agent;International Journal of Pharmaceutics;2019-02